Given the close proximity of the CDKN2A and MTAP genes (see Figure 2), loss of MTAP immunoreactivity has been suggested as a surrogate for CDKN2A HD [32] and has been demonstrated in mesothelioma [57,58]. This evidence concerns the gene MTAP and mesothelioma.